Cutaneous Side-Effects During Therapy of Melanoma by Vemurafenib

Przeglad Dermatologiczny - Poland
doi 10.5114/dr.2015.51923
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Synergistic Effects of Vemurafenib and Fingolimod (FTY720) in Vemurafenib‑resistant Melanoma Cell Lines

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Hypofractionated Radiation Therapy for Node-Positive Cutaneous Melanoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Metastatic Melanoma and Vemurafenib: Novel Approaches

Rare Tumors
OncologyHistology
2012English

Effects of Macrofungal Polysaccharides Combined With Vemurafenib on Melanoma and Its Associated Mechanism

International Journal of Polymer Science
PolymersPlastics
2019English

Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Side Effects of Vasodilator Therapy.

Hypertension
Internal Medicine
1988English

Cutaneous Melanoma

British Journal of Cancer
Cancer ResearchOncology
2001English

Topical Vitamin-A-Acid Therapy for Cutaneous Metastatic Melanoma

The Lancet
Medicine
1980English

Vemurafenib in the Treatment of Brain Metastases From Melanoma

Onkologiya. Zhurnal imeni P.A.Gertsena
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy